AYTU (Aytu BioScience) Stocks and Options Tracker

AYTU

(NASDAQ)

1.19

+0.0100 (+0.85%)

After Hours: 1.17 -0.0200 (-1.68%)

Volume (24h)	Market Cap.	Day Range	52w Range
2.25M	143.53M	1.16 - 1.24	0.34 - 2.99

News Options Financials Holders Transactions Discussions

Sep-23-20 10:00PM	Aytu BioScience to Reschedule Fourth Quarter and FY 2020 Conference CallACCESSWIRE
02:26PM	Aytu BioScience's Earnings OutlookBenzinga
Sep-16-20 12:00PM	Aytu BioScience to Report Fourth Quarter FY 2020 Results and Business Update on Thursday, September 24, 2020ACCESSWIRE
Sep-08-20 12:00PM	Aytu BioScience Announces Global Agreement to Distribute Pinnacle IVD Corporation's 15-Minute COVID-19 Antigen TestACCESSWIRE
Aug-19-20 12:00PM	Aytu BioScience Announces Launch of Nationwide Mobile COVID-19 Testing InitiativeACCESSWIRE
Aug-17-20 03:35PM	Is Aytu BioScience (NASDAQ:AYTU) Using Debt In A Risky Way?Simply Wall St.
12:00PM	Aytu BioScience Announces Manufacture and Delivery of Healight(TM) Devices for Use in COVID-19 Clinical StudyACCESSWIRE
Aug-05-20 03:04PM	LD Micro Announces Preliminary List of Presenters for the LD-500.ACCESSWIRE
Aug-04-20 03:56PM	Aytu (AYTU) to Report Q4 Earnings: What's in the Cards?Zacks
Jul-31-20 09:45PM	Aytu Bioscience, Inc. (AYTU) Outpaces Stock Market Gains: What You Should KnowZacks
Jul-30-20 12:00PM	Aytu BioScience Announces Regulatory Approval of ZolpiMist(R) by Australian Therapeutic Goods AdministrationACCESSWIRE
Jul-27-20 12:00PM	COVID-19 IgG/IgM Rapid Test Cassette Distributed by Aytu BioScience Featured in Business Insider ArticleACCESSWIRE
Jul-20-20 11:30AM	Aytu BioScience Announces Expansion of NATESTO(R) U.S. Commercial TeamACCESSWIRE
Jul-10-20 12:00PM	Aytu BioScience Announces Distribution Partnership with Apollo Med Innovations to Expand Distribution of COVID-19 IgG/IgM Rapid Test in United StatesACCESSWIRE
Jul-07-20 03:30PM	Is Aytu Bioscience (AYTU) Stock Outpacing Its Medical Peers This Year?Zacks
Jun-25-20 04:00PM	All You Need to Know About Aytu Bioscience, Inc. (AYTU) Rating Upgrade to Strong BuyZacks
12:50PM	ASLAN Pharmaceuticals (ASLN) Looks Good: Stock Adds 8.7% in SessionZacks
Jun-25-20 05:50AM	Edited Transcript of AYTU earnings conference call or presentation 14-May-20 8:30pm GMTThomson Reuters StreetEvents
Jun-15-20 02:59PM	bluebird Reports New Data on Betibeglogene Autotemcel for TDTZacks
Jun-12-20 12:47PM	Why Aytu BioScience (AYTU) Stock Might be a Great PickZacks
Jun-11-20 02:21PM	Utragenyx Shares Soar Above 60% YTD on Pipeline DevelopmentsZacks
Jun-10-20 12:37PM	Milestone Pharmaceuticals (MIST) Looks Good: Stock Adds 6.5% in SessionZacks
Jun-09-20 02:00PM	Monopar Therapeutics (MNPR) Catches Eye: Stock Jumps 11.2%Zacks
12:58PM	IDEAYA (IDYA) Looks Good: Stock Adds 10.2% in SessionZacks
Jun-09-20 12:00PM	Aytu BioScience Announces Results from a National Cancer Institute Evaluation of the Company’s Licensed COVID-19 IgG/IgM Rapid TestACCESSWIRE
Jun-08-20 12:00PM	Aytu BioScience Set to Join Russell 3000(R) IndexACCESSWIRE
Jun-05-20 07:13PM	Is Aytu BioScience, Inc. (AYTU) A Good Stock To Buy?Insider Monkey
Jun-03-20 12:00PM	Aytu BioScience Announces Significant Improvement in Natesto(R) Patient Access in the United StatesACCESSWIRE
Jun-02-20 03:30PM	Has Aytu Bioscience (AYTU) Outpaced Other Medical Stocks This Year?Zacks
Jun-01-20 08:01PM	Aytu BioScience Announces $15 Million Debt RetirementACCESSWIRE
12:00PM	Aytu BioScience Announces Emergency Use Authorization of COVID-19 IgG/IgM Rapid TestACCESSWIRE
May-16-20 12:40PM	Aytu BioScience, Inc. (NASDAQ:AYTU): Is Breakeven Near?Simply Wall St.
May-14-20 11:15PM	Aytu Bioscience, Inc. (AYTU) Reports Q3 Loss, Tops Revenue EstimatesZacks
08:01PM	Aytu BioScience Reports Third Quarter Fiscal 2020 Financial ResultsACCESSWIRE
May-11-20 03:30PM	Has Aytu Bioscience (AYTU) Outpaced Other Medical Stocks This Year?Zacks
May-07-20 09:45PM	Aytu Bioscience Inc (AYTU) Outpaces Stock Market Gains: What You Should KnowZacks
12:00PM	Aytu BioScience to Report Fiscal Q3 FY 2020 Results and Business UpdateACCESSWIRE
May-05-20 09:46PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aytu BioSciences, Inc. - AYTUGlobeNewswire
04:30PM	Aytu Bioscience, Inc. (AYTU) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks
May-01-20 01:00PM	Column: How Cedars-Sinai got sucked into the battle over Trump's claim of a COVID-19 treatmentLA Times
Apr-30-20 09:45PM	Aytu Bioscience, Inc. (AYTU) Gains As Market Dips: What You Should KnowZacks
03:45PM	Aytu BioScience Announces China Export Clearance of Company's COVID-19 IgG/IgM Rapid TestACCESSWIRE
Apr-28-20 02:24PM	President Trump Asked If “Light inside the Body” Could Cure COVID-19 — and This Company Wants to Give It a TryTipRanks
Apr-27-20 04:25PM	What's in Store for Aytu BioScience's (AYTU) Q3 Earnings?Zacks
01:55PM	Aytu BioScience Signs Development Agreement with Sterling Medical Devices to Advance the Development of Healight as a Potential Coronavirus TreatmentACCESSWIRE
Apr-24-20 12:00PM	Aytu BioScience Announces Results from Annual Stockholders MeetingACCESSWIRE
Apr-23-20 12:00PM	Aytu BioScience Announces Exclusive Distribution Agreement for COVID-19 IgG/IgM Rapid Test with Singapore-Based Biolidics LimitedACCESSWIRE
Apr-22-20 03:30PM	Is Aytu Bioscience (AYTU) Outperforming Other Medical Stocks This Year?Zacks
12:23AM	The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Aytu BioScience Inc. Investors (AYTU)Business Wire
Apr-21-20 10:30PM	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Aytu BioScience, Inc. (AYTU) on Behalf of InvestorsBusiness Wire

Aytu BioScience, Inc., a specialty healthcare company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and ZolpiMist, an oral spray for the treatment of insomnia. It also offers MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. In addition, the company provides MiOXSYS analyzer, a portable lightweight desktop platform that is used in clinical or research laboratory or near a patient care area; and MiOXSYS disposable sensors. The company is based in Englewood, Colorado.

More Discussions

Anita · September 24, 2020

https://www.linkedin.com/posts/colorado-bioscience-association_strongertogether-cobioscience-colifesciencesinno-activity-6714299021604855808-9vLi

Upvote: 2 · Downvote: 2 · Replies: 0

wiskeydemocrat · September 24, 2020

Anita...Done! And a VM to Carbonara!

Upvote: 10 · Downvote: 2 · Replies: 0

PalmTrees56 · September 24, 2020

Looks like the website earlier was right. Whatever let’s just get this thing on. I’m ready. Tuesday pre market would be ideal anyways over a late Thursday. Just want to get this going

Upvote: 1 · Downvote: 3 · Replies: 0

Anita · September 24, 2020

Added and holding!

Upvote: 6 · Downvote: 3 · Replies: 0

Patrick · September 24, 2020

Shortpercentage is to high. We need much more volume to go up significantly. For those who are interested, ZOG gained 25% in the last 5 days...

Upvote: 7 · Downvote: 0 · Replies: 0

Siempre Mas · September 24, 2020

no fluff news before earnings is great news, earnings will be the news

Upvote: 7 · Downvote: 0 · Replies: 0

Scott · September 24, 2020

Hey Chatty, Three points -I had question marks after press release on Monday??I did rest up on the weekend and I did have a fun week!!!!It’s ok I enjoy your posts, they remind me of when I used to read picture books with my kids.They outgrew that at 5 years old!!!

Upvote: 2 · Downvote: 4 · Replies: 0

Anita · September 24, 2020

Sept 21, 2020Commonwealth Equity Services LLC increased its position in shares of Aytu Bioscience Inc (NASDAQ:AYTU) by 220.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 87,021 shares of the company’s stock after buying an additional 59,840 shares during the period. Commonwealth Equity Services LLC owned about 0.07% of Aytu Bioscience worth $123,000 at the end of the most recent reporting period.

Upvote: 1 · Downvote: 4 · Replies: 0

Althehumbleinvestor · September 24, 2020

I have to be honest and say that I am not sure what to expect tomorrow! This management has been keeping things fairly tight and I am hoping that means they have a lot to share! Unfortunately, I do think that they have to either give us blowout numbers or make some major announcement for this to move significantly to the upside! Anything less than that will mean continuation of the same and most likely pressure to the downside! Now I do feel that given increase in institutional ownership potential downside is probably somewhat limited as those investors will come in and buy cheap shares and provide some level of support! We will see! I hope Josh and Co deliver.

Upvote: 4 · Downvote: 13 · Replies: 0

SoCalDreamer72 · September 24, 2020

Love this quote!Aytu's Chairman and Chief Executive Officer Josh Disbrow will host the call during which the Company expects to report record revenue for its fourth quarter and full fiscal year and progress on the Company's business activities.

Upvote: 20 · Downvote: 9 · Replies: 0

Wiggle Room · September 22, 2020

@Fozz....how did you finish?

Upvote: 3 · Downvote: 0 · Replies: 0

Achilles · September 22, 2020

What is everyone’s average? I am at 1.5. Can’t wait until ER. Let’s go!!!

Upvote: 1 · Downvote: 5 · Replies: 0

Patrick · September 22, 2020

When someone buys over 3.6 million Friday at close, there’s got to come some PR very soon. Hope it will burn all the shorts.

Upvote: 3 · Downvote: 3 · Replies: 0

Fozz · September 22, 2020

BLM has recently removed their manifesto from their website. It contained this: "We disrupt the Western-prescribed nuclear family structure requirement by supporting each other as extended families and "villages.""There is still an archive of this page through:https://web.archive.org/web/20200729021108/https://blacklivesmatter.com/what-we-believe/

Upvote: 3 · Downvote: 1 · Replies: 5

Chatty Off Topic Queen · September 22, 2020

Listen to this guy. He KNOWS how to value a company!wiskeydemocrat 3 years ago Replied to a reaction$INNV conversationI am a long, and as most are, the cost basis is a hell of a lot higher than .09Last trade on a pre-split basis was .011

Upvote: 1 · Downvote: 4 · Replies: 0

MD841 · September 22, 2020

Looking forward to Thursday with the earnings release. Added a few shares today on the dip

Upvote: 5 · Downvote: 1 · Replies: 0

Anita · September 22, 2020

Institutional Investors going up, short interest going down. Going to be the first of many great ER's. AYTU has this!

Upvote: 11 · Downvote: 3 · Replies: 4

RICHARD · September 22, 2020

$1.28 down 10 cents. Nothing like looking good price wise before earnings. Reverse split 1 for 6 on <.03> cents earnings coming. Please list this bad day in excuse order. Let's start with the A order names. Thank you

Upvote: 5 · Downvote: 4 · Replies: 5

Anita · September 22, 2020

June 3, 2020 = Q4 Express ScriptsAytu BioScience Announces Significant Improvement in Natesto(R) Patient Access in the United Stateshttps://finance.yahoo.com/news/aytu-bioscience-announces-significant-improvement-120000333.html

Upvote: 7 · Downvote: 1 · Replies: 0

Anita · September 21, 2020

Well, what have we here?Latest Market Date 2020-09-18Short Volume 1,259,472Market Volume 7,825,200Short Volume Ratio 16%

Upvote: 8 · Downvote: 7 · Replies: 0

Open in Yahoo | Open in Google | Open in Finviz